Hanseo Submitted Five International Patent Filings for Its Liver Medication

Hanseo Pharm Co. Ltd. recently announced the patent filings of its novel medication HS0406, for the treatment of cirrhosis, to the United States, Japan, China, Russia, and Germany.

Hanseo Pharm, which was newly listed on KOSDAQ in November of this year, expects that HS0406 will be proven effective for prevention of liver fat deposition and of cirrhosis progression, and will also help the pat...